Market Reaction to RFK Jr.'s HHS Nomination

In a significant market movement, shares of leading vaccine manufacturers, including Moderna, Pfizer, and BioNTech, experienced a downturn this Tuesday. This shift followed the Senate Finance Committee's advancement of Robert F. Kennedy Jr.'s nomination for the position of Health and Human Services secretary.

Controversial Nomination Moves Forward

The committee's 14-13 party-line vote has propelled the controversial nomination to the Senate floor. Kennedy, a figure known for his critical stance on vaccines, has previously faced backlash for his comments regarding vaccine safety.

Impact on Vaccine Stocks

By 10:41 am ET, the financial repercussions were evident: Moderna's stock decreased by 5.11% to $34.68, BioNTech's shares fell by 2.97% to $116.26, and Pfizer's stock saw a 1.77% reduction to $25.73.